Associations between proportion of plasma phospholipid fatty acids, depressive symptoms and major depressive disorder. Cross-sectional analyses from the AGES Reykjavik Study

  • C. M. Imai
  • T. I. Halldorsson
  • T. Aspelund
  • G. Eiriksdottir
  • L. J. Launer
  • I. Thorsdottir
  • T. B. Harris
  • V. Gudnason
  • I. A. Brouwer
  • Ingibjorg Gunnarsdottir
Article

Abstract

Background

Deficits in n-3 fatty acids may be associated with depression. However, data are scarce from older adults who are at greater risk of poor dietary intake and of developing depression.

Objective

To investigate proportion of plasma phospholipid fatty acids with respect to depressive symptoms and major depressive disorder in community dwelling older adults.

Methods

Cross-sectional analyses of 1571 participants in the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study aged 67-93 years. Depressive symptoms were measured using the 15-item Geriatric Depression Scale (GDS-15). Major depressive disorder was assessed according to Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria using the Mini-International Neuropsychiatric Interview (MINI).

Results

Depressive symptoms were observed in 195 (12.4%) subjects and there were 27 (1.7%) cases of major depressive disorder. Participants with depressive symptoms were less educated, more likely to be smokers, less physically active and consumed cod liver oil less frequently. Difference in GDS-15 scores by tertiles of n-3 fatty acid proportion was not significant. Proportion of long chain n-3 fatty acids (Eicosapentaenoic- + Docosahexaenoic acid) were inversely related to major depressive disorder, (tertile 2 vs. tertile 1) OR: 0.31 (95% CI: 0.11, 0.86); tertile 3 vs. tertile 1, OR: 0.45 (95% CI: 0.17, 1.21).

Conclusion

In our cross sectional analyses low proportions of long chain n-3 fatty acids in plasma phospholipids appear to be associated with increased risk of major depressive disorder. However, the results from this study warrant further investigation in prospective setting with sufficiently long follow-up.

Key words

n-3 fatty acids depression docosahexaenoic acid eicosapentaenoic acid elderly 

References

  1. 1.
    Fiske A, Wetherell JL, Gatz M. Depression in older adults. Annu Rev Clin Psychol 2009;5, 363–389.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Marshall TA, Stumbo PJ, Warren JJ et al. Inadequate nutrient intakes are common and are associated with low diet variety in rural, community-dwelling elderly. J Nutr 2001;131, 2192–2196.PubMedGoogle Scholar
  3. 3.
    Licht-Strunk E, Van Marwijk HW, Hoekstra T et al. Outcome of depression in later life in primary care: longitudinal cohort study with three years’ follow-up. BMJ 2009;338, a3079.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Sontrop J, Campbell MK. Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med 2006;2, 4–13.CrossRefGoogle Scholar
  5. 5.
    Kiecolt-Glaser JK, Belury MA, Porter K et al. Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults. Psychosom Med 2007;69, 217–224.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Feart C, Peuchant E, Letenneur L et al. Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study. Am J Clin Nutr 2008;87, 1156–1162.PubMedGoogle Scholar
  7. 7.
    Grosso G, Pajak A, Marventano S et al. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One 2014;9, e96905.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Bloch MH, Hannestad J. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry 2012;17, 1272–1282.CrossRefPubMedGoogle Scholar
  9. 9.
    Kesse-Guyot E, Touvier M, Andreeva VA et al. Cross-sectional but not longitudinal association between n-3 fatty acid intake and depressive symptoms: results from the SU.VI.MAX 2 study. Am J Epidemiol 2012;175, 979–987.CrossRefPubMedGoogle Scholar
  10. 10.
    Murakami K, Sasaki S. Dietary intake and depressive symptoms: a systematic review of observational studies. Mol Nutr Food Res 2010;54, 471–488.CrossRefPubMedGoogle Scholar
  11. 11.
    Hakkarainen R, Partonen T, Haukka J et al. Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 2004;161, 567–569.PubMedGoogle Scholar
  12. 12.
    Jacka FN, Pasco JA, Henry MJ et al. Dietary omega-3 fatty acids and depression in a community sample. Nutr Neurosci 2004;7, 101–106.CrossRefPubMedGoogle Scholar
  13. 13.
    Beydoun MA, Fanelli Kuczmarski MT, Beydoun HA et al. omega-3 fatty acid intakes are inversely related to elevated depressive symptoms among United States women. J Nutr 2013;143, 1743–1752.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Tiemeier H, van Tuijl HR, Hofman A et al. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr 2003;78, 40–46.PubMedGoogle Scholar
  15. 15.
    Schiepers OJ, de Groot RH, Jolles J et al. Plasma phospholipid fatty acid status and depressive symptoms: association only present in the clinical range. J Affect Disord 2009;118, 209–214.CrossRefPubMedGoogle Scholar
  16. 16.
    Harris TB, Launer LJ, Eiriksdottir G et al. (Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol 2007;165, 1076–1087.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    van Ballegooijen AJ, Visser M, Cotch MF et al. Serum vitamin D and parathyroid hormone in relation to cardiac structure and function: the ICELAND-MI substudy of AGES-Reykjavik. J Clin Endocrinol Metab 2013;98, 2544–2552.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226, 497–509.PubMedGoogle Scholar
  19. 19.
    Schlierf G, Wood P. Quantitative Determination of Plasma Free Fatty Acids and Triglycerides by Thin-Layer Chromatography. Journal of lipid research 1965;6, 317–319.PubMedGoogle Scholar
  20. 20.
    Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. Journal of lipid research 1986;27, 114–120.PubMedGoogle Scholar
  21. 21.
    Eysteinsdottir T, Gunnarsdottir I, Thorsdottir I et al. Validity of retrospective diet history: assessing recall of midlife diet using food frequency questionnaire in later life. J Nutr Health Aging 2011;15, 809–814.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Eysteinsdottir T, Thorsdottir I, Gunnarsdottir I et al. Assessing validity of a short food frequency questionnaire on present dietary intake of elderly Icelanders. Nutr J 2012;11, 12.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Geerlings MI, Sigurdsson S, Eiriksdottir G et al. Associations of current and remitted major depressive disorder with brain atrophy: the AGES-Reykjavik Study. Psychol Med 2013;43, 317–328.CrossRefPubMedGoogle Scholar
  24. 24.
    Valdimarsdottir M, Jonsson JE, Einarsdottir S et al. [Validation of an Icelandic version of the Geriatric Depression Scale (GDS).]. Laeknabladid 2000;86, 344–348.PubMedGoogle Scholar
  25. 25.
    McNamara RK, Hahn CG, Jandacek R et al. (Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 2007;62, 17–24.CrossRefPubMedGoogle Scholar
  26. 26.
    Grosso G, Galvano F, Marventano S et al. Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxid Med Cell Longev 2014, 313570.Google Scholar
  27. 27.
    Wu A, Ying Z, Gomez-Pinilla F. Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 2008;155, 751–759.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Laye S. Polyunsaturated fatty acids, neuroinflammation and well being. Prostaglandins Leukot Essent Fatty Acids 2010;82, 295–303.CrossRefPubMedGoogle Scholar
  29. 29.
    Suominen-Taipale AL, Partonen T, Turunen AW et al. Fish consumption and omega-3 polyunsaturated fatty acids in relation to depressive episodes: a cross-sectional analysis. PLoS One 2010;5, e10530.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Simopoulos AP. Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease. Nutrients 2013;5, 2901–2923.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Sekikawa A, Steingrimsdottir L, Ueshima H et al. Serum levels of marine-derived n-3 fatty acids in Icelanders, Japanese, Koreans, and Americans—a descriptive epidemiologic study. Prostaglandins Leukot Essent Fatty Acids 2012;87, 11–16.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Gunnarsdottir I, Gunnarsdottir BE, Steingrimsdottir L et al. Iodine status of adolescent girls in a population changing from high to lower fish consumption. Eur J Clin Nutr 2010;64, 958–964.CrossRefPubMedGoogle Scholar
  33. 33.
    Thorgeirssdottir H VH, Gunnarsdottir I, Gisladottir E, Gunnarsdottir BE, Thorsdottir I, Stefansdottir J, Steingrimsdottir L. Hvad borda islendingar? Konnun a mataraedi islendinga 2010-2011. Helstu nidursdtodur: Embaetti Landlaeknis, Matvaelastofnun, Rannsofnarstofa i naeringarfraedi vid hashola islands og landspitala, 2011Google Scholar
  34. 34.
    Raeder MB, Steen VM, Vollset SE et al. Associations between cod liver oil use and symptoms of depression: the Hordaland Health Study. J Affect Disord 2007;101, 245–249.CrossRefPubMedGoogle Scholar
  35. 35.
    Imai CM, Halldorsson TI, Eiriksdottir G et al. Depression and serum 25-hydroxyvitamin D in older adults living at northern latitudes-AGES-Reykjavik Study. Journal of nutritional science 2015;4, e37.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Patrick RP, Ames BN. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar, schizophrenia, and impulsive behavior. FASEB J, 2015.Google Scholar
  37. 37.
    Reinders I, Murphy RA, Song X et al. Polyunsaturated fatty acids in relation to incident mobility disability and decline in gait speed; the Age, Gene/Environment Susceptibility-Reykjavik Study. Eur J Clin Nutr 2015;69, 489–493.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Harris TB, Song X, Reinders I et al. Plasma phospholipid fatty acids and fish-oil consumption in relation to osteoporotic fracture risk in older adults: the Age, Gene/Environment Susceptibility Study. Am J Clin Nutr., 2015Google Scholar
  39. 39.
    Haag M. Essential fatty acids and the brain. Can J Psychiatry 2003;48, 195–203.PubMedGoogle Scholar
  40. 40.
    Penninx BW, Kritchevsky SB, Yaffe K et al. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 2003;54, 566–572.CrossRefPubMedGoogle Scholar
  41. 41.
    Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006;83, 1505S–1519S.PubMedGoogle Scholar
  42. 42.
    Sublette ME, Ellis SP, Geant AL et al. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 2011;72, 1577–1584.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011;58, 2047–2067.CrossRefPubMedGoogle Scholar
  44. 44.
    Anderson RJ, Freedland KE, Clouse RE et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24, 1069–1078.CrossRefPubMedGoogle Scholar
  45. 45.
    Arab L. Biomarkers of fat and fatty acid intake. J Nutr 133 Suppl 3, 925S-932S.Google Scholar
  46. 46.
    Mamalakis G, Kalogeropoulos N, Andrikopoulos N et al. Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete. Eur J Clin Nutr 2006;60, 882–888.CrossRefPubMedGoogle Scholar

Copyright information

© Serdi and Springer-Verlag France 2017

Authors and Affiliations

  • C. M. Imai
    • 1
  • T. I. Halldorsson
    • 1
    • 5
  • T. Aspelund
    • 2
    • 4
  • G. Eiriksdottir
    • 2
  • L. J. Launer
    • 3
  • I. Thorsdottir
    • 1
  • T. B. Harris
    • 3
  • V. Gudnason
    • 2
    • 4
  • I. A. Brouwer
    • 6
  • Ingibjorg Gunnarsdottir
    • 1
  1. 1.Unit for Nutrition Research, Landspitali-The National University Hospital of Iceland and Faculty of Food Science and Nutrition, School of Health SciencesUniversity of IcelandReykjavikIceland
  2. 2.Icelandic Heart AssociationKopavogurIceland
  3. 3.National Institute on Aging, Laboratory of Epidemiology, and Population SciencesBethesdaUSA
  4. 4.Faculty of Medicine, School of Health SciencesUniversity of IcelandReykjavikIceland
  5. 5.Centre for Fetal Programming, Department of Epidemiology ResearchStatens Serum InstitutCopenhagen SDenmark
  6. 6.Department of Health Sciences and the EMGO+ Institute for Health and Care Research, Faculty of Earth and Life SciencesVrije Universiteit AmsterdamAmsterdamThe Netherlands

Personalised recommendations